Immix Biopharma, Inc. (ImmixBio) (Nasdaq: IMMX) is a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and other autoimmune diseases. Our lead cell therapy is FDA IND cleared next generation CAR-T NXC-201, currently being evaluated in our ongoing Phase 1b/2 NEXICART-1 (NCT04720313) clinical trial, initiated in February 2021. NXC-201 has the potential to be the world’s first “Single-Day CRS” CAR-T (CRS median onset day 1, median duration 1 day), enabling the potential for a faster return home for patients and supporting ongoing expansion into autoimmune indications. NXC-201 has been awarded Orphan Drug Designation (ODD) by the FDA in both AL Amyloidosis and multiple myeloma, and ODD by the European Commission (EMA) in AL Amyloidosis. Learn more at www.immixbio.com and www.BeProactiveInAL.com.
View Top Employees from Immix Biopharma (Nasdaq: IMMX)| Website | http://immixbio.com |
| Ticker | IMMX |
| Revenue | $3 million |
| Employees | 16 (7 on RocketReach) |
| Founded | 2012 |
| Address | Los Angeles, Los Angeles, California 90064, US |
| Phone | (310) 651-8041 |
| Technologies |
JavaScript,
HTML,
PHP
+14 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Business Services, Science and Engineering, Gaming |
| Competitors | Context Therapeutics, Intensity Therapeutics, Inc., OncoSynergy, VG Life Sciences |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Immix Biopharma (Nasdaq: IMMX) employee's phone or email?
Immix Biopharma (Nasdaq: IMMX) Questions
The Immix Biopharma (Nasdaq: IMMX) annual revenue was $3 million in 2024.
Ben Lyon is the Executive Vice President General Counsel of Immix Biopharma (Nasdaq: IMMX).
7 people are employed at Immix Biopharma (Nasdaq: IMMX).
Immix Biopharma (Nasdaq: IMMX) is based in Los Angeles, California.
The NAICS codes for Immix Biopharma (Nasdaq: IMMX) are [541, 54171, 541714, 54, 5417].
The SIC codes for Immix Biopharma (Nasdaq: IMMX) are [87, 873].
Top Immix Biopharma (Nasdaq: IMMX) Employees
-
25
-
2
-
3
-
1
Related Companies
